Menu
Log In Sign Up
Article

peptide cabergoline Cabergoline decreases the production of prolactin

Published October Oct 18, 2026 7:06 AM

In the specialized field of biochemical research, investigators often explore compounds that interact with the endocrine system to better understand hormonal regulation. Among these, peptide cabergoline—frequently categorized as an ergot-derived dopamine receptor agonist—has garnered significant interest. As an enthusiast of high-purity research chemical compounds, I have found that examining the mechanism of action of such substances provides deep insights into how they function as a potent dopamine receptor and a pituitary gland inhibitor.

The Biochemical P Bergolac stimulates libido, lactation suppression (in women), experience multiple ejaculatory orgasms (in men). Guaranteed delivery to EU, UK, US & AU. rofile of Cabergoline

From a structural and pharmacological perspective, cabergoline (often referenced by its chemical identifier, FCE 21336, or CAS Number: 81409-90-7) is a selective D2-like dopamine receptor agonist. Research indicates that it possesses a high affinity for D2, D3, and 5-HT2B receptors. When evaluating high-purity cabergoline samples, verified through NMR and HPLC testing, it is clear why this compound is considered a long-acting dopamine agonist and prolactin inhibitor.

For those studying hormone regulation, it is essential to note that Cabergoline is a dopamine rec Cabergoline (Dostinex) treats high levels of prolactin. Prolactin is a hormone that's responsible for lactation and certain breast tissue development. eptor agonist that works by preventing prolactin from being released by the pituitary gland. This specific interaction is why it is frequently studied in the context of hyperprolactinemic disorders.

Research Considerations and Observations

When sourcing these materials for laboratory use, quality and purity are paramount. Whether you are working with a Cabergolin Cabergoline: Uses & Dosage - Singapore e Tablet 0.5 mg or a synthetic liquid, the consistency of the compound is critical for reliable data. In my own review of various research-grade sources, I have observed that:

* Cabergoline decre DOSTINEX is indicated for the treatment of dysfunctions related to hyperprolactinaemia, such as amenorrhoea, oligomenorrhoea, anovulation and galactorrhoea.Read more ases the production of prolactin, which is a hormone responsible for several physiological functions.

* The compound, often sold under the brand name Dostinex, is a stable ergot derivative.

* Cabergoline is an ergot derived-dopamine D2-like receptor agonist that requires careful handling and storage to maintain its integrity.

Navigating Research Intent

It is important to understand the scope of this compound's utility. Researchers often investigate how Cabergoline (Dostinex) treats high levels of prolactin in controlled settings. In some academic literat by E Ciccarelli·1989·Cited by 104—Cabergoline (CAB) is a new oral dopaminergic compound showing a very long-lasting PRL-lowering activity and reported to be well tolerated.Read more ure, DOSTINEX is indicated for the treatment of dysfunctions related to hyperprolactinemia, including conditions like amenorrhea or galactorrhea. Furthermore, it can be used to treat certain menstrual problems, fertility problems in men and women in specific clinical scenarios, though my focus remains strictly on the biochemical research aspect.

Because Cabergoline is a long-acting dopamine receptor agonist, researchers must be cautious. As some practitioners note, it is not a benign drug. The potency of the substance means that even at low concentrations, it exerts a powerful effect on the D2 receptors. Whether one is utilizing the tablets or a liquid formulation, understanding the pharmacokinetics is vital.

Practical Insights for Researchers

In my experience, when analyzing the literature, one finds that Cabergoline (CAB) has been studied for decades. Since it was first discovered in 1981, it has remained a staple in endocrine research. While some sources suggest a recommended therapeutic dose: 2-3 mg daily in specific therapeutic pathways, research applications usually involve much smaller, specialized quantities.

When conducting your own inquiries, always remember:

1. High-purity Cabergoline is essential for minimizing experimental variables.

2. Cabergoline is a tablet treatment used to reduce the production of a hormone called prolactin by the pituitary gland, a process that is highly sensitive to dosing.

3. Indicated for hyperprolactinem 31 Jan 2026—It can be used to treat certain menstrual problems, fertility problems in men and women, and pituitary prolactinomas (tumors of the pituitary Read more ic disorders of either idiopathic or pituitary adenoma origin, the compound’s primary mechanism is its ability to modulate the dopamine pathway.

By maintaining a rigorous standard for purity and understanding the complex receptor affini Recommended therapeutic dose: 2-3 mg daily. For adjunctive therapy, a gradual decrease in the dose of concurrent levodopa while increasing the dose of Read more ty of this ergot derivative, those in the research community can continue to map the intricate feedback loops of the endocrine system. Always ensure your sources provide comp The usual dosage involves takingthe tabletsby mouth twice a week. Common side effects of cabergoline include nausea, constipation, headache, and dizziness.Read more rehensive documentation, such as certificates of analysis, to confirm the identity and quality of the CABERGOLINE you are integrating into your studies.

Leave a Comment
Get new articles in your inbox

News, updates and freebies. No spam, unsubscribe anytime.